CRM three-lens brief
Evidence-based stock research on CRM. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved +2.80% yesterday. · Trading at 11% of its 52-week range — deep in the lower band.
- Moved +2.80% yesterday.
- Trading at 11% of its 52-week range — deep in the lower band.
- Underperforming SPY by 17.8pp over 30 days.
- Analyst mean target $268.87 — 51% above current (52 analysts).
- Debt-to-equity of 29.9 — balance-sheet-heavy.
CRM closed at $178.16 (+2.80%) as of 2026-04-25. Market cap: $145.74B. P/E (trailing) 22.8. Positives: moved +2.80% yesterday.; analyst mean target $268.87 — 51% above current (52 analysts).. Concerns: trading at 11% of its 52-week range — deep in the lower band.; underperforming SPY by 17.8pp over 30 days.. Last quarter: Revenue $11.20B, net income $1.94B, free cash flow $16.37B.
Why three lenses on CRM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CRMacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CRM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CRM brief"></iframe>